Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The pharmacogenomic and immune landscape of snoRNAs in human cancers

Cancer Letters(2024)10.1016/j.canlet.2024.217304Source: DataRank Database

The pharmacogenomic and immune landscape of snoRNAs in human cancers is a research paper published in Cancer Letters (2024). On theSindex it has a DataRank of 0.241. It has been cited 4 times.

N/A

0.241DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (16 grants)Impact (FWCI 0.64)OA: greenTopics (46)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.241

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (11)

Chengxuan Chen ORCID,Yuan Liu ORCID,Mei Luo ORCID,H. J. Yang ORCID,Yamei Chen ORCID

Live enrichment

PubMed:39426663 PMC:PMC11898246 OpenAlex:https://openalex.org/W4403540769

Indiana University

Grant: MED230012

National Institutes of Health

Grant: BC230333

National Institutes of Health

Grant: R01HG011633

National Institutes of Health

Grant: R01CA262623

National Institutes of Health

Grant: R01CA255080

National Institutes of Health

Grant: R01CA231011-03S1

National Institutes of Health

Grant: CA269489

National Science Foundation

Grant: 2137603

Track 4: Advanced CI Coordination Ecosystem: Monitoring and Measurement Services

National Science Foundation

Grant: 2138259

Track 1: ACCESS Resource Allocations Marketplace and Platform Services (RAMPS)

National Science Foundation

Grant: 2138296

ACO: An Open CI Ecosystem to Advance Scientific Discovery (OpenCI)

National Science Foundation

Grant: 2138307

Track 3: COre National Ecosystem for CyberinfrasTructure (CONECT)

National Science Foundation

Grant: 2138286

Track 2: Customized Multi-tier Assistance, Training, and Computational Help (MATCH) for End User ACCESS to CI

NCI NIH HHS

Grant: R01 CA231011

NCI NIH HHS

Grant: R01 CA269489

Ralph W. and Grace M. Showalter Research Trust Fund

School of Medicine, Indiana University

FWCI

0.64

Citation Percentile

0.7%

Citation Trend

2025

2026

greenLicense: Elsevier TDM

repositoryhttps://scholarworks.indianapolis.iu.edu/bitstreams/08a93368-598b-4f84-8740-94fc58644e82/download

publisherhttps://api.elsevier.com/content/article/PII:S0304383524006992?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0304383524006992?httpAccept=text/plain

repositoryhttps://hdl.handle.net/1805/52330

Fields of Study

RNA modifications and cancerCancer-related molecular mechanisms researchRNA Interference and Gene Delivery03 medical and health sciences0302 clinical medicineHumansRNA, Small NucleolarNeoplasmsImmunotherapyPharmacogeneticsBiomarkers, TumorGene Expression Regulation, NeoplasticAntineoplastic Agents

MeSH Terms

Antineoplastic AgentsHumansImmunotherapyNeoplasmsPharmacogeneticsBiomarkers, TumorGene Expression Regulation, NeoplasticRNA, Small Nucleolar

Keywords

PharmacogenomicsImmune systemBiologyCancerComputational biologyCancer researchMedicineImmunologyBioinformaticsGeneticsDrug responseSnornaImmune InfiltrationIraeImmune CheckpointImmunotherapy EfficacyGene Expression Regulation, NeoplasticPharmacogeneticsNeoplasmsBiomarkers, TumorHumansRNA, Small NucleolarAntineoplastic AgentsImmunotherapyArticle

Sustainable Development Goals

SDG 0: Good health and well-being